3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Non-Hodgkin
6
Lymphoma
6
Lymphoma, Follicular
5
Lymphoma, Large B-Cell, Diffuse
4
Recurrence
3
Neoplasms
2
Leukemia, B-Cell
2
Burkitt Lymphoma
2
Neoplasm, Residual
1
Mature B-Cell Malignancies
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
5
pembrolizumab
4
durvalumab
4
Carboplatin
4
cemiplimab
3
Radiation
3
Platinum
3
Paclitaxel
3
Cetuximab
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy
2
Pemetrexed
2
Nivolumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
repotrectinib
1
poly ICLC
1
ipatasertib
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
obinutuzumab
×
30 days
×
Clear all
No trials found.